Trust CO Of Vermont Regeneron Pharmaceuticals, Inc. Transaction History

Trust CO Of Vermont

  • $1.98 Billion
  • Q3 2024

A detailed history of Trust CO Of Vermont transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Trust CO Of Vermont holds 157 shares of REGN stock, worth $110,190. This represents 0.01% of its overall portfolio holdings.

Number of Shares
157
Previous 145 8.28%
Holding current value
$110,190
Previous $152,000 8.55%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$1024.09 - $1201.76 $12,289 - $14,421
12 Added 8.28%
157 $165,000
Q2 2024

Jul 09, 2024
BUY
$883.2 - $1071.19 $108,633 - $131,756
123 Added 559.09%
145 $152,000
Q1 2024

May 03, 2024
BUY
$902.69 - $993.35 $18,053 - $19,867
20 Added 1000.0%
22 $21,000
Q4 2023

Mar 08, 2024
SELL
$775.18 - $881.7 $15,503 - $17,634
-20 Reduced 90.91%
2 $1,000
Q2 2023

Jul 17, 2023
SELL
$700.03 - $830.35 $1,400 - $1,660
-2 Reduced 8.33%
22 $15,000
Q1 2023

Apr 07, 2023
BUY
$680.49 - $826.97 $1,360 - $1,653
2 Added 9.09%
24 $19,000
Q2 2022

Jul 20, 2022
BUY
$548.35 - $738.84 $12,063 - $16,254
22 New
22 $13,000
Q1 2022

Apr 05, 2022
SELL
$595.12 - $698.43 $14,282 - $16,762
-24 Closed
0 $0
Q4 2021

Jan 21, 2022
BUY
$543.48 - $670.97 $13,043 - $16,103
24 New
24 $16,000
Q3 2021

Oct 22, 2021
SELL
$574.03 - $680.96 $13,776 - $16,343
-24 Closed
0 $0
Q2 2021

Jul 15, 2021
BUY
$472.8 - $558.54 $1,891 - $2,234
4 Added 20.0%
24 $13,000
Q1 2021

Apr 16, 2021
SELL
$446.73 - $548.2 $2,233 - $2,741
-5 Reduced 20.0%
20 $9,000
Q2 2020

Jul 17, 2020
BUY
$493.32 - $643.92 $2,466 - $3,219
5 Added 25.0%
25 $15,000
Q1 2020

Apr 24, 2020
SELL
$336.18 - $494.43 $5,042 - $7,416
-15 Reduced 42.86%
20 $10,000
Q3 2019

Oct 24, 2019
BUY
$273.46 - $318.39 $4,101 - $4,775
15 Added 75.0%
35 $10,000
Q1 2019

May 01, 2019
SELL
$372.08 - $439.57 $7,441 - $8,791
-20 Reduced 50.0%
20 $8,000
Q4 2018

Jan 30, 2019
SELL
$335.82 - $403.04 $16,791 - $20,152
-50 Reduced 55.56%
40 $14,000
Q2 2018

Jul 11, 2018
BUY
$284.6 - $344.99 $18,783 - $22,769
66 Added 275.0%
90 $31,000
Q3 2017

Oct 24, 2017
BUY
$431.38 - $504.0 $10,353 - $12,096
24
24 $11,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email